The most common issues cited by the FDA were:
- Failure to establish and maintain adequate procedures for implementing corrective and preventative action — 11 citations
- Failure to establish and maintain adequate procedures for receiving, reviewing, and evaluating complaints by a formally designated unit — 8 complaints
- Failure to adequately establish and maintain procedures to control product that does not conform to specified requirements — 7 complaints
- Failure to establish and maintain procedures to ensure that all purchased or otherwise received products and services conform to specified requirements — 6 complaints
Here are the 14 device manufacturers that received warning letters:
- Omega Laser Systems — United Kingdom
- Bedfont Scientific Ltd. — United Kingdom
- Mooncup Ltd. — United Kingdom
- Helica Instruments Ltd. — United Kingdom
- Implants International Ltd. — United Kingdom
- C World KSGnCorporation — Philippines
- A.R.C.O.S. Srl — Italy
- Novastep SAS — France
- F.P. Rubinstein Y Cia SRL — Argentina
- Aussimed Ltd. — Germany
- Spiegelberg Gmbh & Co. KG — Germany
- Shenzhen Creative Industry Co. Ltd. — China
- Beyond Technology Corporation — China
- Master & Frank Enterprises Co. Ltd — China
More articles on medical devices:
Are physicians and medical device reps too buddy-buddy?
Siemens, Insightec partner to expand access to Exablate Neuro technology
FDA approves Thermocool SmartTouch Catheter
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
